Stay updated on Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record for the PERGOLA study of pembrolizumab alongside standard treatment for newly diagnosed glioblastoma is displayed, with details on eligibility, study locations, design, and outcome measures.
    Difference
    42%
    Check dated 2026-11-09T13:25:26.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:17:22.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T16:46:56.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2; the study record remains inaccessible on the error page.
    Difference
    0.2%
    Check dated 2026-10-19T18:08:50.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-12T18:25:17.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, indicating access is blocked and the normal study details are not available at this time.
    Difference
    17%
    Check dated 2026-09-21T22:32:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.